The DOI matches its Crossref record.
Efficacy of Nitazoxanide against Cryptosporidium parvum in Cell Culture and in Animal Models
Open accessAbstract
Nitazoxanide (NTZ), a drug currently being tested in human clinical trials for efficacy against chronic cryptosporidiosis, was assessed in cell culture and in two animal models. The inhibitory activity of NTZ was compared with that of paromomycin (PRM), a drug that is partially effective against Cryptosporidium parvum . A concentration of 10 μg of NTZ/ml (32 μM) consistently reduced parasite growth in cell culture by more than 90% with little evidence of drug-associated cytotoxicity, in contrast to an 80% reduction produced by PRM at 2,000 μg/ml (3.2 mM). In contrast to its efficacy in vitro, NTZ at either 100 or 200 mg/kg of body weight/day for 10 days was ineffective at reducing the parasite burden in C. parvum -infected, anti-gamma-interferon-conditioned SCID mice. Combined treatment with NTZ and PRM was no more effective than treatment with PRM alone. Finally, NTZ was partially effective at reducing the parasite burden in a gnotobiotic piglet diarrhea model when given orally for 11 days at 250 mg/kg/day but not at 125 mg/kg/day. However, the higher dose of NTZ induced a drug-related diarrhea in piglets that might have influenced its therapeutic efficacy. As we have previously reported, PRM was effective at markedly reducing the parasite burden in piglets at a dosage of 500 mg/kg/day. Our results indicate that of all of the models tested, the piglet diarrhea model most closely mimics the partial response to NTZ treatment reported to occur in patients with chronic cryptosporidiosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Rossignol, J.-F. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.07.014 · Cited by 556
Nitazoxanide: A New Thiazolide Antiparasitic Agent
Fox, L. M., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/428839 · Cited by 443
Amadi, B., Mwiya, M., Musuku, J., Watuka, A., Sianongo, S., Ayoub, A., & Kelly, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11401-2 · Cited by 441
Rossignol, J. A., Ayoub, A., & Ayers, M. S. (2001) · The Journal of Infectious Diseases · doi:10.1086/321008 · Cited by 362
Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum
Vinayak, S., Pawlowic, M. C., Sateriale, A., Brooks, C. F., Studstill, C. J., Bar-Peled, Y., Cipriano, M. J., & Striepen, B. (2015) · Nature · doi:10.1038/nature14651 · Cited by 349
Metadata
- Authors
- Theodos, C. M., Griffiths, J. K., D’Onfro, J., Fairfield, A., & Tzipori, S.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1998-08
- Volume
- 42
- Issue
- 8
- Pages
- 1959-1965
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2146576175
- Cited by
- 171
- References
- 0
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of Nitazoxanide against Cryptosporidium parvum in Cell Culture and in Animal Models. https://app.cochat.ai/papers/10.1128/aac.42.8.1959
- The paper
- Theodos, C. M., Griffiths, J. K., D’Onfro, J., Fairfield, A., & Tzipori, S. (1998). Efficacy of Nitazoxanide against Cryptosporidium parvum in Cell Culture and in Animal Models. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.42.8.1959
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.